Clinical Trial Update: A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients [Phase 3]

View source ↗

Summary

Phase 3 long-term study of sibutramine for obesity management and its relation to cardiovascular disease; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Drugs mentioned

• Sibutramine (Meridia) (sibutramine)

Snippet

Sponsor: Abbott | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2010-04-15